TEL AVIV, Israel--(BUSINESS WIRE)--Compugen Ltd. (NASDAQ:CGEN) today reported its results for the second quarter ending June 30, 2009. Included in these results is the financial impact of Compugen’s sale during the quarter, to a single buyer, of 1.0 million of the 2.15 million Evogene Ltd. shares previously held by Compugen, for net proceeds of $3.6 million.
